TABITHA UNDERWOOD: Open Payments
NPI 1891493037 · NEW IBERIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 48 payments from 16 companies in 2025. Trend: 2023 $993 · 2024 $749 · 2025 $1,121
Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $451 |
| GlaxoSmithKline, LLC. | 10 | $237 |
| Amgen Inc. | 4 | $79 |
| Insmed, Inc. | 4 | $78 |
| Viatris Specialty LLC | 2 | $48 |
| Verona Pharma, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
Products named: FASENRA, TEZSPIRE, NUCALA, FARXIGA, Arikayce, TRELEGY ELLIPTA, YUPELRI, Ohtuvayre.
Industry payments across LA — which companies pay providers there.
